| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
IO Biotech (NASDAQ:IOBT) reported its Q3 earnings results on Monday, November 13, 2023 at 08:12 AM.
Here's what investors need to know about the announcement.
IO Biotech beat estimated earnings by 2.27%, reporting an EPS of $-0.43 versus an estimate of $-0.44.
Revenue was down $0 from the same period last year.
Last quarter the company missed on EPS by $0.1 which was followed by a 0.0% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for IO Biotech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IOBT
